logo
Allow us to reduce EWS obligation: Indraprastha Apollo Hospital moves plea before SC

Allow us to reduce EWS obligation: Indraprastha Apollo Hospital moves plea before SC

Indian Express21-05-2025

The Indraprastha Apollo Hospital in Delhi has moved an intervention application before the Supreme Court, requesting that it be allowed to reduce its EWS (Economically Weaker Sections) obligation to 10% in the In-Patient Department (IPD) and 25% in the Out-Patient Department (OPD).
If this proposal is accepted, the hospital would no longer be bound to maintain 200 EWS beds. Instead, it would be required to provide around 70 such beds, marking a significant shift in its obligation to serve the economically weaker sections.
At present, while 33% of the IPD and 40% of the OPD of the hospital cater to the EWS category, medicines and consumables are not provided free of cost to these patients, though they receive free treatment.
In an affidavit submitted to the SC on May 14, Indraprastha Medical Corporation Limited (IMCL) — which runs the hospital — submitted that it is ready to provide free treatment, along with free medicines and consumables, if it is allowed to use only 10% of its IPD and 25% of the OPD to treat EWS patients.
This comes after the SC had warned the hospital on March 25 that it would direct the All India Institute of Medical Sciences (AIIMS) to take over its management if it failed to fulfill its land lease commitment given to the state government to provide free treatment to poor patients.
At 26%, the Delhi government has the largest stake in the hospital, which was handed over 15 acres of land on lease at a token rent of Re 1 per month.
Institutions like hospitals and schools, which get land from the government on concessional rates, are obligated, as per the terms of their lease, to provide free services to those from the EWS category.
In the affidavit, the IMCL has said that despite the recommendations of the Qureshi Committee, it remained bound by the terms of the lease deed, which imposed a 'higher and more onerous obligations of 33% free IPD and 40% OPD'.
In 2001, a report by a committee set up by the Delhi government, led by Justice A S Qureshi (retd), had recommended 25% OPD and 10% indoor services for EWS patients in private hospitals and nursing homes that had received land on concessional rates.
The IMCL also said that the obligation to provide 33% free IPD and 40% free OPD services resulted in a disproportionate burden on it. 'This happened because of the loss of exemption from customs duty and other benefits,' it added.
Further, the hospital said that while it had expressed willingness to purchase the land given on lease by the government, due to DDA policies, the land could not be allocated directly to a private company. The land was then allotted to the Delhi government, which in turn was leased to the IMCL.
The affidavit also submitted said that the Delhi government has received over Rs 87 crore till date as dividends from the hospital, and its original equity investment of Rs 23.83 crore has appreciated to about Rs 900 crore.
As per the court's instructions, the hospital submitted the existing bed strength and records of OPD and IPD patients for the last five years.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Poinguinim boar attack victim compensated
Poinguinim boar attack victim compensated

Time of India

time2 hours ago

  • Time of India

Poinguinim boar attack victim compensated

Canacona: The forest department paid a compensation of Rs 85,000 to Jayanti Velip, who developed deformities from a wild boar attack in Jan. The compensation papers were prepared by the assistant conservator of forests (South) Harsh Phadte and range forest officer, Canacona, Anant Velip, under the supervision of the deputy conservator of forests (South), Satish Kumar Reddy. Velip was working in a paddy field at Velwada, Poinguinim when a wild boar attacked her from behind. She fought with the boar and suffered injuries, resulting in 82% disability to her thumb and ear, she told TOI . After the attack, she was hospitalised for over two months and is now unable to use her right thumb or hear properly with her one ear. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !

Indian pharma market grows 7.2% in May led by chronic therapies
Indian pharma market grows 7.2% in May led by chronic therapies

Business Standard

time3 hours ago

  • Business Standard

Indian pharma market grows 7.2% in May led by chronic therapies

Indian pharma market grew 7.2% in May with strong performance in chronic therapies such as cardiac and anti-infectives, along with gains from price hikes and new launches Sanket Koul New Delhi The Indian Pharma Market (IPM) grew 7.2 per cent in May this year with almost all major therapies showing positive growth, according to market research firm Pharmarack. Data suggest that big chronic therapies such as cardiac and anti-infectives, which account for nearly 25 per cent of the overall domestic market, recorded value growth of 11.7 per cent and 7.6 per cent, respectively. On the other hand, several smaller supergroups such as urology and antineoplastics, which made up 2 per cent each of the IPM's sales value for the month, also recorded double-digit growth in May at 12.3 per cent and 11.7 per cent, said Sheetal Sapale, vice-president, commercial, Pharmarack. Data suggest that the overall value growth for the IPM in May was driven by price growth and new introductions. The IPM also reported a minuscule 0.4 per cent unit growth during the month, with the chronic segments such as antidiabetics (6.1 per cent) and cardiac (4.8 per cent) performing better than the overall market figure. Experts believe that the antidiabetic segment saw a 6.1 per cent rise in volume in May due to a key drug, empagliflozin, going off-patent, as companies launched several plain and combination medications in the segment. Growth in the moving annual turnover (MAT) for the IPM between June 2024 and May 2025 stood at 8.1 per cent, leading to a total turnover of over Rs 2.29 trillion, while volumes in the domestic market grew by 1.1 per cent. The MAT of leading therapy areas such as cardiac, gastrointestinal and anti-infectives, which constitute around 38 per cent of the pharmaceutical market, showed robust volume growth at 10.4 per cent, 9.5 per cent and 6.5 per cent, respectively. While the top 20 brands in the IPM registered modest monthly value growth in the domestic market during the month, Sun Pharma and Dr Reddy's posted significant monthly value growth at 11.2 per cent each. They were followed by Torrent Pharma and Ipca Laboratories at 10.8 per cent, and Alkem Laboratories at 10.3 per cent monthly value growth. According to Pharmarack data, GlaxoSmithKline's (GSK) antibiotic medication Augmentin and USV's anti-diabetic drug Glycomet GP continued to be the top-selling medicine brands at the MAT level, with sales worth Rs 819 crore and Rs 810 crore, respectively.

FDA shuts 3 food businesses at Patradevi, Margao
FDA shuts 3 food businesses at Patradevi, Margao

Time of India

time4 hours ago

  • Time of India

FDA shuts 3 food businesses at Patradevi, Margao

Panaji: The food and drugs administration (FDA) directed two food business operators—a restaurant and a cashew shop—to suspend operations at Patradevi, Pernem, due to unhygienic conditions. The FDA inspected 18 outlets at Patradevi, issued improvement notices, and gave them 14 days to comply. They seized Rs 50,000 worth of food items, including chips, chocolates, and dry fruits with artificial colours. Samples of sweets were also taken for testing. The FDA also directed a restaurant in Margao to shut down for failing to pay a fine and for non-compliance with FDA directions following its inspection on April 28. They found that only 5 of 30 deficiencies were addressed and ordered the food operator to stop all activities and submit a compliance report. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store